Experiment 533406

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationHOFFMANN,J: SPENGLER,M:. (1994). EFFICACY OF 24-WEEK MONOTHERAPY WITH ACARBOSE, GLIBENCLAMIDE, OR PLACEBO IN NIDDM PATIENTS.. 17(6)
Amount utilized
Compound isolated
Disease96 NIDDM PATIENTS WERE STUDIED (FOR 24 WEEKS). DOES NOT INCREASE POSTPRANDIAL INSULIN (ADVANTAGE OVER GLIBENCLA(MIDE).
Dose amount300.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
GenderMALE